CRISPR Therapeutics

CRISPR Therapeutics is a leading gene editing company that develops CRISPR/Cas9-based therapies to treat genetic diseases and engineer advanced cellular therapies. The company has achieved a historic milestone with CASGEVY, the first-ever approved CRISPR-based therapy for severe sickle cell disease and transfusion-dependent beta-thalassemia, and maintains strategic partnerships with industry leaders like Bayer and Vertex Pharmaceuticals. Their therapeutic portfolio spans hemoglobinopathies, immuno-oncology, autoimmune disorders, cardiovascular disease, and type 1 diabetes.

Company Facts

• Headquarters: Zug, Switzerland
• Founded: 2013
• Employees: 393
• Type: Public Corporation
• Website: https://www.crisprtx.com
• Industries: Biotechnology, Gene Editing, Pharmaceuticals, Healthcare, Therapeutics